Pediatrix schedules November 2 results for Pediatrix Medical Group stock
Published on 10/15/2026 at 22:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting calendar and valuation
- Pediatrix Medical Group's next earnings date is November 2, 2026.
- Second-quarter earnings per share reached USD 0.63 on August 4, 2026.
- Pediatrix Medical Group stock costs EUR 24.70 at Lang & Schwarz on October 15, 2026 at 10:43 p.m. CEST.
- The company has a USD 2.3 billion market capitalization and a P/E ratio of 13.28.
Pediatrix Medical Group is scheduled to report its next results on November 2, 2026, according to MarketBeat. The date gives investors the next fixed checkpoint after the company's second-quarter update. Pediatrix Medical Group stock was trading at EUR 24.70 at Lang & Schwarz on October 15, 2026 at 10:43 p.m. CEST.
Second-quarter earnings set the baseline
The company reported second-quarter earnings per share of USD 0.63 on August 4, 2026, above the USD 0.59 consensus cited by MarketBeat. Revenue increased 4.10 percent year over year, while the quarter's reported earnings figure provides the clearest operating comparison before the November report.
The second-quarter result also needs to be read alongside volume pressure. A recent company earnings summary described stronger revenue-cycle-management collections, payer mix and patient acuity as offsets to lower patient-service volumes.
Stock sits near its yearly high
The primary-market quote was USD 27.76 at 4:00 p.m. ET on October 15, 2026, while the 52-week range ran from USD 16.02 to USD 27.94. The current level therefore sits USD 0.18 below the yearly high. The session volume was 478,945 shares against an average of 751,560.
Valuation and the November date
Pediatrix Medical Group had a market capitalization of USD 2.3 billion and a P/E ratio of 13.28. The company does not currently pay a dividend. MarketBeat lists a USD 26.60 consensus target and six analysts, placing the upcoming report ahead of a closely watched valuation checkpoint.
Comparison with peers
MD (NYSE, USD): P/E 13.28, market capitalization USD 2.3 billion
Universal Health Services (NYSE, USD): plus 0.79 percent, P/E 7.68, market capitalization USD 11.0 billion
HCA Healthcare (NYSE, USD): minus 0.41 percent, P/E 15.68, market capitalization USD 101.4 billion
Trading perspective
Pediatrix combines a price near its 52-week high with a lower P/E ratio than HCA Healthcare and a higher P/E ratio than Universal Health Services. The November 2 reporting date is the next concrete point at which revenue growth, earnings and patient volumes can be assessed together.
The further course of trading is shown by the continuously updated real-time quote of Pediatrix Medical Group stock.
Pediatrix Medical Group market data
- Company: Pediatrix Medical Group, Inc.
- ISIN: US58502B1061
- Ticker: MD
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 10:43 p.m. CEST): EUR 24.70
- Market capitalization: USD 2.3 billion (as of October 15, 2026)
- 52-week range: USD 16.02-27.94 (as of October 15, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
- Next earnings date: November 2, 2026
Market context: Market report S&P 500.
